Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai‐Dong Zhu, Jian Wang, Bin‐Yan Zhong et al.|Signal Transduction and Targeted Therapy|2023Cited by 295
Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort studyYushan Zhao, Yi Chen, Shu-Wei Wen et al.|Frontiers in Immunology|2024Cited by 7